Heart failure HF is a common condition affecting approximately 5. It accounts for about 1. Since this study, the number of patients living with chronic HF has progressively increased. This review will discuss the diagnosis and treatment of AHF as directed by the various guidelines that comment on this disease. The signs and symptoms of AHF can include dyspnea on exertion DOE , orthopnea, paroxysmal nocturnal dyspnea PND , fatigue, edema, weight gain, positive jugular venous distention JVD , rales, pulmonary edema, tachycardia, ventricular filling murmur S 3 , cool extremities, or poor urine output. Forrester et al developed a classification system for AMI that placed patients into groups based on hemodynamic parameters cardiac output and pulmonary capillary wedge pressure [PCWP] and clinical presentation hypoperfusion or volume overload.
Role and Value of Clinical Pharmacy in Heart Failure Management
Heart Failure Transitions of Care: A Pharmacist-Led Post-Discharge Pilot Experience
Coronary heart disease CHD is one of the leading reasons patients visit a health care provider, with more than 14 million ambulatory visits for CHD in Over patients per year experience a new myocardial infarction MI or recurrent acute coronary syndrome ACS. Almost 1 million patients per year undergo percutaneous coronary intervention PCI , whereby a bare metal or drug-eluting stent is placed within a coronary artery because of angina or MI. Therefore, working with patients and other health care practitioners to prevent recurrent ACS MI, and stroke in these complex patients is a vital role for pharmacists. Statins also reduce the risk of stroke.
A Pharmacist’s Guide for Systolic Heart Failure
KG is a year-old man presenting to the outpatient heart failure HF clinic for his scheduled 6-month follow-up appointment. He notes feeling short of breath when walking up 1 flight of stairs and has had difficulty dressing himself on occasion. KG also complains of some dyspnea on exertion and has had a persistent, nonproductive cough.
Q: BC, a year-old man, approaches the pharmacy counter looking for advice. Recently, he was seen by a cardiologist at the recommendation of his primary care physician, and after undergoing an electrocardiogram and an evaluation, he was told that he has mild mitral valve regurgitation. BC says that his doctor did not initiate any new drugs to treat this disorder, and he is not completely sure what self-care measures are necessary for this condition. BC is looking for advice on what lifestyle modifications, if any, he should consider making. Upon questioning, BC says that he is a cigarette smoker and has a history of hypertension and hyperlipidemia, managed on a combination of amlodipine, valsartan, hydrochlorothiazide, and atorvastatin.